Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Akari Therapeutics plc ADR (0.01 USD) (AKTX)

Pharmaceutical Preparations

https://www.akaritx.com

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. It operates mainly in United States and United Kingdom.

24 WEST 40TH STREET, 8TH FLOOR
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/07/2012

Market Cap

29,062,052

Shares Outstanding

13,201,690,000

Weighted SO

5,653,451

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ARMP --.--%

ANEB --.--%

SCPS --.--%

PCSA --.--%

SLRX --.--%

AXLA --.--%

MGTA --.--%

HSTO --.--%

Beta

0.9140

Last Div

0.0000

Range

1.078-4.4

Chg

0.2700

Avg Vol

23790

Mkt Cap

29062052

Exch

NASDAQ

Country

GB

Phone

44 20 8004 0270

DCF Diff

2.6844

DCF

0.7856

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.9589

P/FV

-6.5694

Div Yield %

0.0000

P/E

-1.4986

PEG

-0.1759

Payout

0.0000

Current Ratio

0.4383

Quick Ratio

0.4383

Cash Ratio

0.2071

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

90.0777

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0000

ROA

-5.6187

ROE

50.6692

ROCE

6.4144

NI/EBT

1.0000

EBT/EBIT

0.6834

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

-0.7802

Rec Turnover

0.0000

Pay Turnover

4.0521

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-2.0248

FCF/Share

-2.0248

Cash/Share

0.1947

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-6.5694

P/B

-6.5694

P/S

0.0000

P/E

-1.4986

P/FCF

-2.1338

P/OCF

-1.7138

P/CF

-1.7138

PEG

-0.1759

P/S

0.0000

EV Multiple

-0.9589

P/FV

-6.5694

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation